IRADIMED CORPORATION IRMD
81.11 USD +1.69 (+2.13%)
At closeNov 3, 2026, 4:00 PM EST
81.11 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
79.14 Day range 81.41
76.35 52-week range 107.90
- YTD
- -16.62%
- 1 year
- -3.57%
Analyst view
Consensus: buy
Buy
Price target (mean) 118.00 +45.5% upside
Now 81.11
- Target (low)
- 116.00
- Target (mean)
- 118.00
- Target (high)
- 120.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy0
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.60333 | 0.59 – 0.62 | 0.54 | +11.7% | 25.57M | +12.7% | 3 |
| Next quarter | 0.57333 | 0.56 – 0.59 | 0.49 | +17.0% | 24.55M | +11.7% | 3 |
| Current year | 2.10 | 2.09 – 2.11 | 1.93 | +8.6% | 92.05M | +9.8% | 3 |
| Next year | 2.43 | 2.40 – 2.47 | 2.10 | +16.1% | 102.30M | +11.1% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 22, 2026 | Needham | Initiated | — | Hold |
| Apr 2, 2026 | Freedom Broker | Initiated | — | Buy |
| Feb 14, 2025 | Roth MKM | Reiterated | Buy | Buy |
| Aug 2, 2024 | Roth MKM | Maintained | Buy | Buy |
| Aug 2, 2021 | Roth Capital | Maintained | — | Buy |
| Jul 31, 2017 | Roth Capital | Upgrade | Neutral | Buy |
| Oct 5, 2016 | Roth Capital | Downgrade | Buy | Neutral |
| Apr 4, 2016 | Roth Capital | Maintained | — | Buy |
| Jun 16, 2015 | Roth Capital | Maintained | — | Buy |
| Aug 11, 2014 | Roth Capital | Initiated | — | — |